Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Niccoli

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Seminars in Arthritis and Rheumatism|April 14, 2004
Are polymyalgia rheumatica and giant cell arteritis the same disease?Fabrizio Cantini, Laura Niccoli, Lara Storri, et al.
Clinical Rheumatology|June 6, 2008
Fast spin echo-T2-weighted sequences with fat saturation in toe dactylitis of spondyloarthritisIgnazio Olivieri, Enrico Scarano, Angela Padula, et al.
Therapeutics and Clinical Risk Management|May 6, 2020
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical DataMaurizio Benucci, Arianna Damiani, Francesca Li Gobbi, et al.
The Journal of Rheumatology|January 6, 2004
Fat suppression magnetic resonance imaging in shoulders of patients with polymyalgia rheumaticaFabrizio Cantini, Carlo Salvarani, Laura Niccoli, et al.
The Journal of Rheumatology|April 3, 2003
Treatment of refractory polymyalgia rheumatica with infliximab: a pilot studyCarlo Salvarani, Fabrizio Cantini, Laura Niccoli, et al.
Arthritis and Rheumatism|August 12, 2003
Efficacy of infliximab in resistant psoriatic arthritisCarlo Salvarani, Fabrizio Cantini, Ignazio Olivieri, et al.
Autoimmunity Reviews|January 25, 2015
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practiceFabrizio Cantini, Carlotta Nannini, Laura Niccoli, et al.
Arthritis and Rheumatism|February 8, 2005
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup studyCarlo Salvarani, Fabrizio Cantini, Laura Niccoli, et al.
Therapeutics and Clinical Risk Management|December 1, 2018
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variablesLaura Niccoli, Carlotta Nannini, Corrado Blandizzi, et al.
Seminars in Arthritis and Rheumatism|April 18, 2017
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Seminars in Arthritis and Rheumatism|April 14, 2004
Are polymyalgia rheumatica and giant cell arteritis the same disease?Fabrizio Cantini, Laura Niccoli, Lara Storri, et al.
Clinical Rheumatology|June 6, 2008
Fast spin echo-T2-weighted sequences with fat saturation in toe dactylitis of spondyloarthritisIgnazio Olivieri, Enrico Scarano, Angela Padula, et al.
Therapeutics and Clinical Risk Management|May 6, 2020
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical DataMaurizio Benucci, Arianna Damiani, Francesca Li Gobbi, et al.
The Journal of Rheumatology|January 6, 2004
Fat suppression magnetic resonance imaging in shoulders of patients with polymyalgia rheumaticaFabrizio Cantini, Carlo Salvarani, Laura Niccoli, et al.
The Journal of Rheumatology|April 3, 2003
Treatment of refractory polymyalgia rheumatica with infliximab: a pilot studyCarlo Salvarani, Fabrizio Cantini, Laura Niccoli, et al.
Arthritis and Rheumatism|August 12, 2003
Efficacy of infliximab in resistant psoriatic arthritisCarlo Salvarani, Fabrizio Cantini, Ignazio Olivieri, et al.
Autoimmunity Reviews|January 25, 2015
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practiceFabrizio Cantini, Carlotta Nannini, Laura Niccoli, et al.
Arthritis and Rheumatism|February 8, 2005
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup studyCarlo Salvarani, Fabrizio Cantini, Laura Niccoli, et al.
Therapeutics and Clinical Risk Management|December 1, 2018
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variablesLaura Niccoli, Carlotta Nannini, Corrado Blandizzi, et al.
Seminars in Arthritis and Rheumatism|April 18, 2017
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Pageof 5